Clear Street lowered the firm’s price target on Core Scientific (CORZ) to $25 from $27 and keeps a Buy rating on the shares. The absence of a new lease announcement this quarter reflects timing and exclusivity dynamics, not any deterioration in underlying demand, contends the analyst, who continues to view Core Scientific as well positioned into 2026.
Meet Samuel – Your Personal Investing Prophet
COZX: an alternative to margin or options on CORZPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance
- Core Scientific pivots to high-density colocation amid restatements
- Core Scientific reports Q4 EPS 42c vs (69c) last year
- Core Scientific, Inc options imply 16.4% move in share price post-earnings
- These Are the Stocks Reporting Earnings Today – March 2, 2026